BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Charles River Laboratories International Inc.

NYSE: CRL    
Share price (11/22/24): $195.77    
Market cap (11/22/24): $10.0 billion

Material Contracts Filter

EX-10.6
from 10-K 4 pages Terms and Conditions of Restricted Stock Unit Award
12/34/56
EX-10.2
from 10-K 20 pages Charles River Laboratories International, Inc. Amended and Restated 2018 Incentive Plan Originally Adopted by the Board of Directors on March 20, 2018 Approved at Annual Meeting of Shareholders on May 8, 2018 Amended by the Board of Directors on March 14, 2020 Amendment and Restatement Approved at Annual Meeting of Shareholders on May 6, 2020 Amended by the Administrator (The Compensation Committee of the Board of Directors) on November 21, 2023
12/34/56
EX-10.1
from 10-Q 4 pages Flavia Pease [***] Subject: Employment Offer Letter
12/34/56
EX-10.18
from 10-K 4 pages Private & Confidential Mr D.R. Smith [***] 14 February 2022 Dear David, Compensation Changes & Succession Terms
12/34/56
EX-10.2
from 8-K 5 pages Charles River Laboratories International, Inc. 2018 Incentive Plan Performance Share Unit Award Agreement
12/34/56
EX-10.1
from 8-K 4 pages Charles River Laboratories International, Inc. Granted Under 2018 Incentive Plan Restricted Stock Unit Award
12/34/56
EX-10.3
from 10-Q 13 pages Amended and Restated Deferred Compensation Plan Document February 8, 2006
12/34/56
EX-10.2
from 10-Q 4 pages The Executive Incentive Compensation Program (“Eicp” or the “Program”) of Charles River Laboratories, Inc. (The “Company”) Is Designed to Focus Employees at the Vice President (“Vp”) Level and Higher on the Achievement of Organizational, Financial and Operational Goals That Have Been Identified as Important for the Success of the Company. the Program Is Also Intended to Attract, Motivate and Retain Talented Individuals With Desired Skills in a Competitive Labor Market. Definitions as Used Herein, the Following Terms Shall Have the Following Meanings: “Annual Base Salary” Refers to a Participant’s Base Rate of Pay, Annualized, as of November 30 of the Program Year. It Does Not Include Any Additional Payments That May Have Been Made Such as Commissions, Bonus Payments, Overtime Pay or Imputed Income. “Award Amount” Is a Value in Local Currency Determined for Each Participant by Multiplying the Participant's Target Award by Their Funding Percentage. “Compensation Committee”: The Compensation Committee of the Board of Directors of the Company “Funding Percentage” Is Determined for Each Participant by the Adding Together the Weighted Performance for the Metrics Applicable to Such Participant, Based on the Funding Scale Approved by the Compensation Committee From Time to Time. “Participant” Means an Employee of the Company Who Is Eligible to Participate in the Eicp. “Program Year” Means the Applicable Company Fiscal Year. “Target Award” Means a Participant’s Targeted Award Amount Which Is Determined by Multiplying the Participant’s Annual Base Salary by His or Her Target Percentage. “Target Percentage” Is a Pre-Determined Percentage of a Participant’s Annual Base Salary. Target Percentages Are Determined Based on a Participant’s Assigned Job Level. Eligibility
12/34/56
EX-10.1
from 10-Q 23 pages Private & Confidential Charles River Discovery Research Services Uk Limited (1) & David Ross Smith (2) Service Agreement
12/34/56
EX-10.1
from 8-K 12 pages Support Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Personal and Confidential October 26, 2020
12/34/56
EX-10.1
from 10-Q 2 pages Personal and Confidential October 26, 2020
12/34/56
EX-10.3
from 10-Q 6 pages Form of Charles River Laboratories International, Inc. 2018 Incentive Plan Performance Share Unit Award Agreement
12/34/56
EX-10.2
from 10-Q 5 pages Charles River Laboratories International, Inc. Granted Under 2018 Incentive Plan Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 4 pages Charles River Laboratories International, Inc. Non-Qualified Stock Option Granted Under 2018 Incentive Plan
12/34/56
EX-10.1
from 10-Q 20 pages Charles River Laboratories International, Inc. Amended and Restated 2018 Incentive Plan Originally Adopted by the Board of Directors on March 20, 2018 Approved at Annual Meeting of Shareholders on May 8, 2018 Amended by the Board of Directors on March 14, 2020 Amendment and Restatement Approved at Annual Meeting of Shareholders on May 6, 2020
12/34/56
EX-10.1
from 10-Q 4 pages Agreement
12/34/56
EX-10.2
from 10-Q 4 pages Charles River Laboratories International, Inc. Granted Under 2018 Incentive Plan Restricted Stock Unit Award
12/34/56
EX-10.1
from 10-Q 3 pages Insert Vesting Table
12/34/56
EX-10.3
from 10-Q 5 pages Consulting Agreement
12/34/56